constructed the signature of seven IFN-γ-related lncRNAs to assess prognosis in patients with lung adenocarcinoma, in which the high-risk group had a worse prognosis and was associated with high levels of tumor-promoting immune cells (51). This evidence concerns the gene IFNG and lung adenocarcinoma.